Sign in

CIK 0001022899

  • Non-accelerated filer
  • Smaller reporting company

Protagenic Therapeutics, Inc.new

Sign in to watch
Ticker
PTIX
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
061390025
Phone
+1 212-994-8200
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
  1. 4 Open-market buy See Remarks bought 60,211 shares at $1.25 ($75,264)
  2. 4 Grant or award Director acquired 150,000 shares (grant or award)
  3. 4 Grant or award Director acquired 45,000 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 140,000 shares (grant or award)
  5. 4 Grant or award See Remarks acquired 500,000 shares (grant or award)
  6. 4 Grant or award Director acquired 45,000 shares (grant or award)
  7. 4 Grant or award Director acquired 45,000 shares (grant or award)
  8. 4 Grant or award Director acquired 40,000 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 7 · 137 filings